|
Building on the success of our earlier kickstarter competition in the UK, Australia, Israel, and Italy, we are excited to announce the launch of the 5th edition of o2h kickstarter, exclusively tailored for early-stage biotech companies based in the USA.
o2h discovery has now supported many companies through launching its discovery kickstarter competition in several of the world's most exciting biotech clusters, and now we aim to bring our biotech start-up machinery to the largest and most successful biotech ecosystems in the world, the USA. o2h discovery has been working with Venture Capital and early-stage biotech companies in the USA since 2003 to support their drug discovery efforts, and several of these companies have been acquired by big pharma or have continued to an IPO on the NASDAQ. Through our kickstarter award, we seek to support the next generation of biotech investors and entrepreneurs.
o2h kickstarter competition 5.0 is being launched to support USA based early stage biotech companies that have secured initial funding, have exciting drug targets, and have the ability to scale, but need expert services to supercharge their chemistry efforts to meet the next scientific and funding milestones. The aim of our kickstarter program is to support the next wave of USA biotechnology companies to get off the ground.
|
